Hot Papers

D. Kim, D.L. Lewis, L. Graziadei, E.J. Neer, D. Bar-Sagi, D.E. Clapham, "G-protein áç-subunits activate the cardiac muscarinic K+-channel via phospholipase A2," Nature, 337, 557-60, 9 February 1989. David Clapham (Mayo Foundation, Rochester, Minn.): "More than 70 (for example, à,á, muscarinic, and rhodopsin) receptor types are linked to their effectors via G proteins. These G proteins are composed of two functional subunits, known as Gà and Gáà. Although the e

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

D. Kim, D.L. Lewis, L. Graziadei, E.J. Neer, D. Bar-Sagi, D.E. Clapham, "G-protein áç-subunits activate the cardiac muscarinic K+-channel via phospholipase A2," Nature, 337, 557-60, 9 February 1989. David Clapham (Mayo Foundation, Rochester, Minn.): "More than 70 (for example, à,á, muscarinic, and rhodopsin) receptor types are linked to their effectors via G proteins. These G proteins are composed of two functional subunits, known as Gà and Gáà. Although the evidence that the Gà subunit activates effectors is well known, we proposed in an earlier paper that in some cases the Gáà subunit may also activate an effector, the cardiac muscarinic-gated potassium channel (Logothetis, et al., Nature, 325: 321-6, 1987). This idea was controversial, since most evidence supports Gáà's main role to be as an inhibitor of Gà. This paper proposed that Gáà activates the cardiac potassium channel via stimulation of phospholipase A2 and subsequent generation of arachidonic acid and its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies